No need debate about the huge potential of Buddy...
Just wonder if anyone can shed light on the favorite one mentioned at the end of the quoted article "Our favourite – a tiny Aussie partnering with giants
Our third stock is, hands down, our favourite. It’s a tiny Aussie medical tech company with a market cap of just $126 million. But it’s already a leader in developing and commercializing computerized solutions for brain function measurement and analysis. In fact, it works with nine of the top 10 global pharmaceutical companies, such as Pfizer, Johnson & Johnson, and Lilly and Merck...."
BUD Price at posting:
22.5¢ Sentiment: None Disclosure: Held
